Loading clinical trials...
Loading clinical trials...
The study is a randomized, double-blind, placebo-controlled clinical study of the efficacy and safety of divozilimab in patients with systemic scleroderma.The study will enroll adult patients of both ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Biocad
NCT07343115 · Systemic Scleroderma
NCT07090226 · Systemic Scleroderma, Diffuse Cutaneous Scleroderma
NCT07326033 · Systemic Scleroderma
NCT03816189 · Systemic Sclerosis, Systemic Scleroderma
NCT03508375 · Systemic Scleroderma
Chelyabinsk Regional Clinical hospital
Chelyabinsk
Clinical Rheumatology Hospital №25
Saint Petersburg
North-Western state Medical University named after I.I. Mechnikov
Saint Petersburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions